Company Successfully Surpasses 1,000th Implantation Milestone for its Strong and Bio-integrative OSSIOfiber® Technology WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation technology company, today announced that its OSSIOfiber® Compression Screw...
Latest News and Updates
OCV Partners Assist Portfolio Company Social Native in Acquiring Olapic to Create Next-Gen Creative Optimization Platform
LOS ANGELES–(BUSINESS WIRE)–Social Native, a marketplace technology company that empowers marketers to source and optimize visual content to improve brand awareness and performance, announced today the acquisition of Olapic, a leading user-generated, influencer, and...
OCV Partners Participates in Finch Therapeutics’ Oversubscribed $90 Million Financing to Advance its Pipeline of Investigational Oral Microbiome Drugs
Proceeds to support the advancement of lead candidate through the final stages of clinical development for recurrent C. difficile infection, and the advancement into the clinic of programs for autism spectrum disorder and chronic hepatitis B.Somerville, MA, September...
SafeBreach Raises $19 Million to Expand Channels, Accelerate Product Development
Experiencing rapid customer growth, the industry’s leading provider of breach-and-attack simulation will use the funding to accelerate the development of new product capabilities and services, expand strategic partnerships and grow its channel relationships with major...
OCV Partners Co-leads By Heart’s $70M Series A Financing Ahead of First Product Launch in 2021
Lead Investors Include Polaris Partners, D1 Capital Partners, and OCV Partners in the Over-Subscribed Round; Former Pfizer Baby Nutrition Leader, as well as Former CEO of J2 Global (What to Expect, BabyCenter and Everyday Health) Join the ByHeart Board of DirectorsNEW...
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System
Complete Offering of Implant Sizes and Shapes Provides Surgeons and their Patients an Intelligent Bone Regeneration Alternative to Metal FixationWOBURN, Mass — OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber® Hammertoe Fixation System...
Finch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101, an Investigational Oral Full-Spectrum Microbiota® Therapy for the Prevention of Recurrent C. difficile Infection
– 206 patients randomized at 51 centers in a multinational, placebo-controlled trial– Topline data expected at the end of Q2 2020Somerville, MA (January 8, 2020) — Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome therapeutics company, announced...
Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas
Somerville, MA (August 22, 2019) — Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced today the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna...
Museum of Ice Cream Founders Launch Figure8 with Series A to Transform How Millennials and Gen-Z Connect With Spaces and Each Other
Funding led by Elizabeth Street Ventures, Maywic Select Investment, and OCV PartnersNew York, NY (August 14, 2019) — Founders of Museum of Ice Cream, Maryellis Bunn and Manish Vora, launch Figure8, an experience-first development company. Figure8, now parent company...
OSSIO Secures $22 Million in Financing
Proceeds to Be Used for US Commercialization and Operational ExpansionWOBURN, MA., March 11, 2019 — OSSIO, an orthopedic fixation company, today announced the closing of $22 million in equity financings led by OCV Partners, a Los Angeles based venture capital firm,...
Invoice2go Raises $10 Million, Attracting New and Existing Investors, and Hemi Zucker from OCV Partners to join the Board of Directors
REDWOOD CITY, Calif., Sept 11, 2018 — Invoice2go announces it has closed a $10 million equity round led by OCV Partners, with additional participation from existing investors Accel and Ribbit Capital. Hemi Zucker of OCV Partners joins the Invoice2go Board of...
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
DURHAM, North Carolina, USA, June 26 2018 –Precision BioSciences today announced the closing of an oversubscribed $110M Series B financing to further product development efforts based on its ARCUS® genome editing platform. The financing was led by ArrowMark Partners...
Hemi Zucker to Join OCV Management as Managing Principal
LOS ANGELES – OCV Management LLC (“OCV”), a technology investor based in Los Angeles, announced today that Nehemia (“Hemi”) Zucker will be joining the firm as Managing Principal starting on January 1, 2018. Until such date, Hemi will continue as CEO of j2 Global Inc....
With our decades of company building experience, we look to create asymmetric advantages when backing winning teams.